Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic disease

Annals of Otology, Rhinology and Laryngology

Volumn 118, Issue 3, 2009, Pages 205-210

  Capaccio, Pasquale ^a,d   Cuccarini, Valeria ^a   Ottaviani, Francesco ^a,d,e   Fracchiolla, Nicola Stefano ^b   Bossi, Anna ^c   Pignataro, Lorenzo ^a  

^a Department of Otorhinolaryngological and Ophthalmological Sciences ^*

^b Operative Unit of Hematology

^c Institute of Medical Statistics

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiovascular thrombotic disease; MTHFR gene mutation; Platelet gene mutation; Prothrombin gene mutation; Sudden sensorineural hearing loss; V Leiden gene mutation

Indexed keywords

CHOLESTEROL; DNA; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO ACID BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; AUDIOMETRY; BLOOD EXAMINATION; CARDIOVASCULAR DISEASE; COCHLEA BLOOD FLOW; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA ISOLATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; GENE MUTATION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; LEUKOCYTE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERCEPTION DEAFNESS; PERFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; STROKE; THROMBOCYTE COUNT; THROMBOSIS;

EID: 62449325160     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940911800308     Document Type: Article

References (29)

1. Capaccio P, Ottaviani F, Cuccarini V, et al. Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 2007;117:547-51.
2. Almawi WY, Ameen G, Tamin H, Finan RR, Irani-Hakime N. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in angiographically documented coronary artery disease. J Thromb Thrombolysis 2004;17:199-205.
3. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003;146:948-57.
4. Szolnoki Z, Somogyvári F, Kondacs-A,et al. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry 2003;74:1615-20.
5. Aznar J, Mira Y, Vayá A, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost 2004;91:1031-4.
6. Harrington DJ, Malefora A, Schmeleva V, et al. Genetic variations observed in arterial and venous thromboembolism relevance for therapy, risk prevention and prognosis. Clin Chem Lab Med 2003;41:496-500.
7. Reuner KH, Elgas M, Kaps M, Ruf A, Patscheke H. The human platelet antigen HPA-1a/1b (Pl(A1)Pl(A2)) polymorphism and cerebral ischaemia. Thromb Haemost 1997;78:964-5.
8. Marcucci R, Giusti B, Betti I, et al. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 2003;110:7-12.
9. Görür K, Tuncer U, Eskandari G, Ozcan C, Unal M, Ozsahinoglu C. The role of factor V Leiden and prothrombin G20210A mutations in sudden sensorineural hearing loss. Otol Neurotol 2005;26:599-601.
10. Rudack C, Langer C, Junker R. Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss. Hear Res 2004;191:41-8.
11. Rudack C, Langer C, Stoll W, Rust S, Walter M. Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95:454-61.
12. Gross M, Friedman G, Eliashar R, et al. Impact of methionine synthase gene and methylenetetrahydrofolate reductase gene polymorphisms on the risk of sudden sensorineural hearing loss. Audiol Neurootol 2006;11:287-93.
13. Patscheke JH, Arndt J, Dietz K, Zenner HP, Reuner KH. The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients. Thromb Haemost 2001;86:1118-9.
14. Suckfüll M, Wimmer C, Jäger B, Schorn K, Thiery J. Heparin-induced extracorporeal low-density-lipoprotein precipitation (H.E.L.P.) to improve the recovery of hearing in patients cwith sudden idiopathic hearing loss. Eur Arch Otorhinolaryngol 2000;257:59-61.
15. Suckfüll M, Wimmer C, Reichel O, Mees K, Schorn K. Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 2002;23:309-11.
16. Hirano K, Ikeda K, Kawase T, et al. Prognosis of sudden deafness with special reference to risk factors of microvascular pathology. Auris Nasus Larynx 1999;26:111-5.
17. Valbonesi M, Mora F, Mora R, Carlier P. Rheopheresis for sudden hearing loss (SHL). Int J Artif Organs 2004;27:806-9.
18. Cadoni G, Agostino S, Scipione S, Galli J. Low serum folate levels: a risk factor for sudden sensorineural hearing loss? Acta Otolaryngol 2004;124:608-11.
19. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost 1999;81:733-8.
20. Sacchi E, Tagliabue L, Duca F, Mannucci PM. High frequency of the C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 1997;78:963-4.
21. De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. Semin Thromb Hemost 2000;26:305-11.
22. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002;87:1095-108.
23. Kastrati A, Schomig A, Seyfarth M, et al. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 1999;99:1005-10.
24. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-53.
25. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997;22:130-1, 134-8.
26. Marchiori A, Mosena L, Prins MH, Prandoni P The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 2007; 92:1107-14.
27. Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/ PLA2 and coronary risk: a meta-analysis. Thromb Haemost 2001;85:626-33.
28. van Guldener C, Stehouwer CD. Hyperhomocysteinaemia and vascular disease-a role for DNA hypomethylation? Lancet 2003;361:1668-9.
29. Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: too many tests, too much conflicting data. Hematology Am Soc Hematol Educ Program 2002:353-68.